Psychiatry Medical News about MedMAP Schizophrenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prescriber Fidelity to a Medication Management Evidence-Based Practice in the Treatment of Schizophrenia
Psychiatric Services, 07/02/09

Howard PB et al. - Implementation and monitoring of MedMAP were feasible in these community mental health settings. Additional implementation projects are crucial for advancing evidence-based practice in clinical settings.

Methods

This three-year longitudinal intervention study implemented MedMAP in six community mental health centers in Kentucky.
Nine psychiatrists and five advanced practice psychiatric nurses with prescriptive authority participated in the study.
Prescribers were trained in the use of MedMAP about one month before implementation, and MedMAP principles were reinforced throughout the study.
Four posttraining assessments were conducted at each site at approximately four-month intervals over a period of 30 months.
An 18-item scale was used to assess baseline and posttraining prescriber fidelity over a period of 30 months in 900 randomly selected medical records.

Results

Average fidelity scores improved significantly over baseline at each of the four postimplementation fidelity assessments.
Training effects were most evident at the second posttraining fidelity assessment, but effects persisted over the course of the study.
There was considerable variability in scores across items both at baseline and subsequently.
Posttraining improvement was greatest in patient education, documentation of illness and medication history, and simplification of medication regimen.

<< Previous
Genetic and non-genetic influences on the development of...

Next >>
DSM-IV personality disorders in the WHO World Mental Health...

Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09 Relevance Score: 46%

Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09 Relevance Score: 46%

Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09 Relevance Score: 46%

Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09 Relevance Score: 46%

Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09 Relevance Score: 46%